Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
140.87
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S ADR
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
53
54
Next >
Did Novo Nordisk Just Get a Jump on Eli Lilly?
March 19, 2024
A recent FDA announcement may have just put one company in the lead.
Via
The Motley Fool
Exposures
Product Safety
Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
March 19, 2024
Winfrey dedicated a prime-time special to discussing the stigma surrounding weight loss and the use of drugs like Ozempic and Mounjaro
Via
Benzinga
LifeMD Shares Come Back to Life on GLP-1 Business Growth
March 19, 2024
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
Via
MarketBeat
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
March 19, 2024
Madrigal has one key advantage over its two huge potential future rivals.
Via
The Motley Fool
Exposures
Product Safety
Novo Nordisk Options Trading: A Deep Dive into Market Sentiment
March 18, 2024
Via
Benzinga
Is NYSE:NVO suited for dividend investing?
March 18, 2024
Is NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) suited for dividend investing?
Via
Chartmill
Novo Nordisk Is Already Working on Wegovy's Successor -- Time to Buy?
March 17, 2024
The company continues to impress investors.
Via
The Motley Fool
Here's How Much $100 Invested In Novo Nordisk 10 Years Ago Would Be Worth Today
March 15, 2024
Via
Benzinga
Inconsistent Insurance Coverage For Weight Loss Drugs - Novo Nordisk's GLP-1s Face Hurdles Despite Health Benefits
March 18, 2024
Debate ensues over insurance coverage for Novo Nordisk's Wegovy following FDA approval. Evernorth's EncircleRx introduces financial guarantee, aiming to control costs and improve accessibility....
Via
Benzinga
Exposures
Product Safety
US Prescriptions Race For Weight Loss Drugs - Eli Lilly's Zepbound Overtakes Novo Nordisk's Wegovy
March 18, 2024
Latest in weight-loss medication trends: Eli Lilly And Co's Zepbound (tirzepatide) surges past rival Novo Nordisk A/S's Wegovy (semaglutide) in new prescriptions, signaling a shift in the obesity...
Via
Benzinga
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) Exhibits Quality Stock Traits. Here's Why.
March 18, 2024
Why NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) should be investigated by quality investors.
Via
Chartmill
Novo Nordisk Isn't in The "Magnificent Seven," but Here's Why I Think It Should Be
March 17, 2024
The drugmaker is magnificent in its own right.
Via
The Motley Fool
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
March 17, 2024
There's no need for delays in buying these great stocks.
Via
The Motley Fool
Smart Money Is Betting Big In NVO Options
March 14, 2024
Via
Benzinga
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Via
The Motley Fool
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
March 17, 2024
Free two-day shipping for Prime members and a direct-to-consumer sales model could accelerate sales of Eli Lilly's Zepbound.
Via
The Motley Fool
7 Mega-Cap Stocks That Can Turn $10,000 Into $1 Million
March 15, 2024
These million dollar mega-cap stocks will continue to produce big winners in 2024 and beyond as they continue to rise.
Via
InvestorPlace
Novo Nordisk Just Scored a Huge Win. And It's Not Related to Ozempic
March 15, 2024
Novo Nordisk might be best known for Ozempic, but the company just received positive news from the FDA for an entirely different drug.
Via
The Motley Fool
Exposures
Product Safety
3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold
March 15, 2024
If you want to take advantage of the red-hot growth in weight-loss stocks, these are three companies that you can own a piece of today.
Via
InvestorPlace
Move Over, Tesla! These 6 Stocks Could Replace It in the "Magnificent 7"
March 15, 2024
Tesla is failing to keep pace with the rest of the Magnificent Seven.
Via
The Motley Fool
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
March 15, 2024
Viking Therapeutics just might be an attractive acquisition target for Pfizer.
Via
The Motley Fool
3 Pharma Stocks to Sell in March Before They Crash & Burn
March 14, 2024
Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.
Via
InvestorPlace
Is WW Stock on the Brink of Bankruptcy?
March 14, 2024
It's hard to see what WW, the company formerly called Weight Watchers, can do now that Oprah Winfrey has turned against it.
Via
InvestorPlace
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
March 13, 2024
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates.
Via
Benzinga
Eli Lilly Taps Amazon's Pharmacy To Deliver Meds, Including Weight-Loss Drug Zepbound
March 13, 2024
The company is bolstering the ways it delivers medicines through its new LillyDirect website.
Via
Investor's Business Daily
Pharmaceutical Crime Jumps 50% As Criminals Seek To Capitalize Rising Tide of Counterfeit Weight-Loss Drugs
March 13, 2024
Combatting counterfeit weight-loss drugs: Insights into the surge, global impact, and efforts by pharmaceutical giants like Novo Nordisk and Eli Lilly to protect consumers.
Via
Benzinga
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
March 13, 2024
WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD).
Via
MarketBeat
Why Novo Nordisk Stock Was a Winner Today
March 12, 2024
A team of analysts believes the popular company has excellent potential for future growth.
Via
The Motley Fool
Newly Listed Obesity Player Fractyl Health Shares Encouraging Preclinical Data
March 12, 2024
Fractyl Health unveils RJVA-001, a groundbreaking GLP-1 gene therapy for metabolic diseases. Promising preclinical results show durable blood sugar and weight reduction in diabetes mouse model.
Via
Benzinga
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant
March 12, 2024
The pharma giant could have yet another knockout obesity drug on the way.
Via
The Motley Fool
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
53
54
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.